Epoetin-associated pure red cell aplasia: past, present, and future considerations

BACKGROUND: Since 1988, millions of patients have received epoetin products intravenously (IV) and subcutaneously. In 1998, epoetin-associated pure red cell aplasia (PRCA) was first reported and causation was attributed to formulations without human serum albumin (HSA), subcutaneous administration,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: McKoy, June M., Stonecash, Robin E., Cournoyer, Denis, Rossert, Jerome, Nissenson, Allen R., Raisch, Dennis W., Casadevall, Nicole, Bennett, Charles L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2730535/
https://ncbi.nlm.nih.gov/pubmed/18482185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2008.01749.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares